ArticleResearch square2026
Functional Depth Biomarkers Distinguish Lung Squamous Cell Carcinoma from Lung Adenocarcinoma.
Article in Research square, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Lung squamous cell carcinoma (LUSC) and lung adenocarcinoma (LUAD) exhibit fundamentally distinct pathway coordination architectures. We developed a framework integrating pathway activity inference from spatial transcriptomics data, spatial proximity based network construction, and functional depth analysis across 996 TCGA patients. Applying Fraiman-Muniz depth statistics, we generated two representations: Population Referenced Depth quantifies typicality relative to population distributions, while Patient Referenced Depth assesses within-patient network organization. Random forest classification revealed that Patient Referenced Depth marginally outperforms population comparisons, achieving test AUC of 0.768. We focus on bidirectional interaction patterns obtained from spatial interaction networks of pathways. Multi-method feature integration identified three mechanistic frameworks distinguishing subtypes: myeloid orchestrated immune coordination (JAK-STAT ↔ TNF
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.